US-based RoosterBio Inc. has appointed MBL Beijing Biotech, a subsidiary of JSR Life Sciences Company, as its exclusive distributor in China. MBL will handle sales and distribution of RoosterBio’s expansion media, exosome collection media, bioreactor media, and genetic engineering media to local clients.
Product Portfolio
RoosterBio’s engineered media are used in the development of mesenchymal stem/stromal cell therapies and exosome therapies. The partnership aims to expand access to these products in China’s growing cell therapy market.
Operational Details
MBL will begin accepting orders for RoosterBio’s products from September 2022, supporting developers of advanced therapies with high-quality media solutions.-Fineline Info & Tech
